Abstract
ABSTRACTObjective: The main aim of this research is to reduce the dimension of the epileptic Electroencephalography (EEG) signals and then classify it usingvarious post classifiers. For the evaluation and easy treatment of neurological diseases, EEG signals are used. The reflection of the electrical activitiesof the human brain is obtained by the measurement of potentials in EEG. To study and explore the brain functions in an exhaustive manner, EEG is usedby both physicians and scientists. The study of the electrical activity of the brain which is done through EEG recording is a vital tool for the diagnosis ofmany neurological diseases which include epilepsy, sleep disorders, injuries in head, dementia etc. One of the most commonly occurring and prevalentneurological disorders is epilepsy and it is easily characterized by recurrent seizures.Methods: This paper employs the concept of dimensionality reduction concepts like Fuzzy Mutual Information (FMI), Independent ComponentAnalysis (ICA), Linear Graph Embedding (LGE), Linear Discriminant Analysis (LDA) and finally Variational Bayesian Matrix Factorization (VBMF).The epilepsy risk levels are also classified using post classifiers like Singular Value Decomposition (SVD), Approximate Entropy (ApEn) and WeightedKNN (W-KNN) classifiers.Results: The highest accuracy is obtained when LDA is combined with Weighted KNN (W-KNN) Classifiers and it is of 97.18%. Conclusion: Thus the EEG signals not only represent the brain function but also the status of the whole body. The best result obtained was whenLDA is engaged as a dimensionality reduction technique followed by the usage of the W-KNN as post classifier for the classification of epilepsy risklevels from EEG signals. Future work may incorporate the possible usage of different dimensionality reduction techniques with various other types ofclassifiers for the perfect classification of epilepsy risk levels from EEG signals.Keywords: FMI, ICA, LGE, LDA, W-KNN, EEG
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Asian Journal of Pharmaceutical and Clinical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.